CoChat

Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases

Open access
Gao, Ju, Wang, Luwen, Liu, Jingyi, Xie, Fei, Su, Bo, Wang, Xinglong · 2017 · Antioxidants

The DOI matches its Crossref record; 177 of the 178 references it cites were found in a registry or an index.

Abstract

Neurodegenerative diseases are incurable and devastating neurological disorders characterized by the progressive loss of the structure and function of neurons in the central nervous system or peripheral nervous system. Mitochondria, organelles found in most eukaryotic cells, are essential for neuronal survival and are involved in a number of neuronal functions. Mitochondrial dysfunction has long been demonstrated as a common prominent early pathological feature of a variety of common neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). Mitochondria are highly dynamic organelles that undergo continuous fusion, fission, and transport, the processes of which not only control mitochondrial morphology and number but also regulate mitochondrial function and location. The importance of mitochondrial dynamics in the pathogenesis of neurodegenerative diseases has been increasingly unraveled after the identification of several key fusion and fission regulators such as Drp1, OPA1, and mitofusins. In this review, after a brief discussion of molecular mechanisms regulating mitochondrial fusion, fission, distribution, and trafficking, as well as the important role of mitochondrial dynamics for neuronal function, we review previous and the most recent studies about mitochondrial dynamic abnormalities observed in various major neurodegenerative diseases and discuss the possibility of targeting mitochondrial dynamics as a likely novel therapeutic strategy for neurodegenerative diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antiox6020025

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic depiction of mitochondrial dynamics in mammalian cells. (A) Cytosolic Drp1 is recruited to the mitochondrial outer membrane by several receptor proteins, followed by oligomerization into ring-like structures to partially constrict the mitochondrial membrane. Then, another dynamin-like protein, dynamin 2 (Dyn2), binds and constricts the mitochondrial membrane further to enable lipid fusion and organelle division; (B) The mitochondrial fusion process requires two steps, outer membrane fusion and inner membrane fusion. Outer membrane fusion is mediated through interactions of coiled-coil domains of Mfn1 and Mfn2 to form either homo-oligomeric or hetero-oligomeric complexes to tether membranes together. OPA1 is involved in the formation of cristae junctions as well as in inner membrane fusion; (C,D) The anterograde motor kinesin-1 and the retrograde motor dynein/dynactin complex directly interact with Milton and Miro on mitochondria to drive their movement along the microtubules; (E) Actin motors are associated with mitochondria to facilitate the short-distant movement along the filament.
Figure 1 Schematic depiction of mitochondrial dynamics in mammalian cells. (A) Cytosolic Drp1 is recruited to the mitochondrial outer membrane by several receptor proteins, followed by oligomerization into ring-like structures to partially constrict the mitochondrial membrane. Then, another dynamin-like protein, dynamin 2 (Dyn2), binds and constricts the mitochondrial membrane further to enable lipid fusion and organelle division; (B) The mitochondrial fusion process requires two steps, outer membrane fusion and inner membrane fusion. Outer membrane fusion is mediated through interactions of coiled-coil domains of Mfn1 and Mfn2 to form either homo-oligomeric or hetero-oligomeric complexes to tether membranes together. OPA1 is involved in the formation of cristae junctions as well as in inner membrane fusion; (C,D) The anterograde motor kinesin-1 and the retrograde motor dynein/dynactin complex directly interact with Milton and Miro on mitochondria to drive their movement along the microtubules; (E) Actin motors are associated with mitochondria to facilitate the short-distant movement along the filament.CC BY · PubMed Central
Figure 2 Impaired mitochondrial dynamics in neurodegenerative diseases. (A) Mitochondrial fragmentation is a common factor in neurodegeneration, leading to impaired mitochondrial function and increased cell death. Disease-associated proteins such as phosphorylated Tau, Aβ, LRRK2 G2019S, SOD1 G93A, and mutant Htt disturb the delicate mitochondrial dynamics, including fusion, fission, and trafficking, resulting in mitochondrial dysfunction. Manipulation of mitochondrial dynamics by genetic or chemical approaches may be a useful strategy to restore mitochondrial function and promote neuronal survival; (B) Mitochondrial dynamic abnormalities impair mitochondria transport and proper localization, leading to mitochondrial depletion in neurites and synapses and eventually neuronal death.
Figure 2 Impaired mitochondrial dynamics in neurodegenerative diseases. (A) Mitochondrial fragmentation is a common factor in neurodegeneration, leading to impaired mitochondrial function and increased cell death. Disease-associated proteins such as phosphorylated Tau, Aβ, LRRK2 G2019S, SOD1 G93A, and mutant Htt disturb the delicate mitochondrial dynamics, including fusion, fission, and trafficking, resulting in mitochondrial dysfunction. Manipulation of mitochondrial dynamics by genetic or chemical approaches may be a useful strategy to restore mitochondrial function and promote neuronal survival; (B) Mitochondrial dynamic abnormalities impair mitochondria transport and proper localization, leading to mitochondrial depletion in neurites and synapses and eventually neuronal death.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 177 references

Cited by

See all 250

Metadata

Authors
Gao, J., Wang, L., Liu, J., Xie, F., Su, B., & Wang, X.
Affiliations
  • Case Western Reserve University (US)
  • Shandong University (CN)
Corresponding author
Wang, Xinglong
Venue
Antioxidants
Publisher
MDPI AG
Published
2017-04-05
Volume
6
Issue
2
Pages
25
ISSN
2076-3921 (ISSN-L)
OpenAlex
W2604387140
Cited by
250
References
178
Citations by year
2026: 11 · 2025: 27 · 2024: 28 · 2023: 27 · 2022: 27 · 2021: 34 · 2020: 31 · 2019: 28 · 2018: 30 · 2017: 7
FWCI
2.46
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Alzheimer's Association (AARG-17-499682)
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (R01NS097679)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
mitochondrial dynamics, neurodegenerative diseases, mitochondrial fusion, mitochondrial fission, mitochondrial transport, Drp1, OPA1, mitofusins, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, mitochondrial dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases. https://app.cochat.ai/papers/10.3390/antiox6020025
The paper
Gao, J., Wang, L., Liu, J., Xie, F., Su, B., & Wang, X. (2017). Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases. Antioxidants. https://doi.org/10.3390/antiox6020025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.